| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
| filingDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aac0b4548e0dee8047b5bada9152ec0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43b849c02227a76986617bd8961a99b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272a4e116ded53b229e307db9f2b9a2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7369e67adcb377233a693002a52859 |
| publicationDate |
2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3128043-A1 |
| titleOfInvention |
Treatment of ciliopathies using inhibitors of glucosylceramide synthase (gcs) |
| abstract |
This disclosure relates to a method of treating a ciliopathy in a subject, the method comprising administering to the subject an effective amount of a quinuclidine compound. Also disclosed is a pharmaceutical composition comprising a quinuclidine compound for use in said method. |
| priorityDate |
2019-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |